Pathogenesis of murine coronavirus in the central nervous system.
Pathogenesis of murine coronavirus in the central nervous system.
复制标题
DOI:
10.1007/s11481-010-9202-2
复制
发表时间:
2010-09
影响因子:
6.2
通讯作者:
Weiss, Susan R.
中科院分区:
文献类型:
--
作者:
Bender, Susan J.;Weiss, Susan R.
Murine coronavirus (mouse hepatitis virus, MHV) is a collection of strains that induce disease in several organ systems of mice. Infection with neurotropic strains JHM and A59 causes acute encephalitis, and in survivors, chronic demyelination, the latter of which serves as an animal model for multiple sclerosis. The MHV receptor is a carcinoembryonic antigen-related cell adhesion molecule, CEACAM1a; paradoxically, CEACAM1a is poorly expressed in the central nervous system (CNS), leading to speculation of an additional receptor. Comparison of highly neurovirulent JHM isolates with less virulent variants and the weakly neurovirulent A59 strain, combined with the use of reverse genetics, has allowed mapping of pathogenic properties to individual viral genes. The spike protein, responsible for viral entry, is a major determinant of tropism and virulence. Other viral proteins, both structural and nonstructural, also contribute to pathogenesis in the CNS. Studies of host responses to MHV indicate that both innate and adaptive responses are crucial to antiviral defense. Type I interferon is essential to prevent very early mortality after infection. CD8 T cells, with the help of CD4 T cells, are crucial for viral clearance during acute disease and persist in the CNS during chronic disease. B cells are necessary to prevent reactivation of virus in the CNS following clearance of acute infection. Despite advances in understanding of coronavirus pathogenesis, questions remain regarding the mechanisms of viral entry and spread in cell types expressing low levels of receptor, as well as the unique interplay between virus and the host immune system during acute and chronic disease.
登录
查看更多内容
DOI:
10.1084/jem.90.3.195
发表时间:
1949-08-31
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Bailey OT;Pappenheimer AM;Cheever FS;Daniels JB
通讯作者:
Daniels JB
影响因子:
5.4
作者:
Butler, Noah S.;Dandekar, Ajai A.;Perlman, Stanley
通讯作者:
Perlman, Stanley
影响因子:
11.8
作者:
Chiu, SS;Chan, KH;Peiris, JSM
通讯作者:
Peiris, JSM
影响因子:
5.4
作者:
Das Sarma, J;Fu, L;Lavi, E
通讯作者:
Lavi, E
影响因子:
5.3
作者:
Changolkar, Lakshmi N.;Singh, Geetika;Pehrson, John R.
通讯作者:
Pehrson, John R.